MiR-1224-5p attenuates polycystic ovary syndrome through inhibiting NOD-like receptor protein 3 inflammasome activation via targeting Forkhead box O 1
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that poses a great threat to women's health. MiR-1224-5p is downregulated in the follicular fluid of patients with PCOS, but its role remains largely unknown. In this study, mice were treated with dehydroepiandrosterone (DHEA) to e...
Guardado en:
Autores principales: | Yan Li, Nianling Yao, Yan Gao, Yunping Wang, Lu Bai, Jia Xu, Haixu Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4647694deb114d3db1bd8dd500dea72e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
por: Ran Y, et al.
Publicado: (2021) -
Effect of the Treatment with Dexamethasone, for 10 and 15 Days, on the Fertility in Induced Rats to Polycystic Ovaries, by Constant Illumination
por: Moraes,Eleonora de Figueiredo, et al.
Publicado: (2008) -
Evaluation of the Estral Cycle in Rats after Treatmen twith Dexamethasone for Polycystic Ovaries, Induced by Constant Illumination
por: Barros,Heitor Arôxa, et al.
Publicado: (2006) -
METABOLIC AND NUTRITIONAL INTERFACES IN POLYCYSTIC OVARY SYNDROME: CONSIDERATIONS REGARDING OBESITY AND DIETARY MACRONUTRIENTS
por: Rodrigues de O. P.,Fernanda, et al.
Publicado: (2009) -
MODERN CONCEPTS OF THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME (LITERATURE REVIEW)
por: O. V. Panarina, et al.
Publicado: (2017)